iSpecimen Launches Marketplace Onsite Program to Optimize Biospecimen Procurement Process for Sample Providers
October 04 2022 - 7:30AM
iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an
online global marketplace that connects scientists in need of
biospecimens for medical research with a network of healthcare
specimen providers, today launched its new Marketplace Onsite
program to offer additional support to the Company’s biospecimen
provider partners. The program embeds a coordinator at select
partner sites to facilitate fulfillment of incoming sample and data
requests from the proprietary iSpecimen Marketplace® platform. With
this extra layer of support, iSpecimen and its partners will be
able to expand and streamline access to biospecimens for research.
The Marketplace Onsite coordinator will field all requests and
submit proposals on behalf of the provider, streamlining
sample-related management and reducing strain on existing staff and
product pipelines. The Marketplace Onsite program will also help
with building and contracting with a network of researchers,
providing remuneration for biospecimens and data, offering IT
assistance for data management needs and covering the expenses of
the iSpecimen Onsite employee.
“The Marketplace Onsite program is the first of many internal
initiatives focused on addressing our supplier constraints, which
will allow us to grow our revenue further,” said Tracy Curley,
interim CEO, iSpecimen. “This initiative aims to further support
and expand our provider network while increasing access to
biospecimens that are in high-demand or traditionally harder to
find. We remain steadfast in our mission to connect scientists with
healthcare providers that have access to patients and biospecimens
needed for key medical advancements.”
About iSpecimen Marketplace The iSpecimen
Marketplace is a novel technology platform that connects life
sciences researchers who need biospecimens for their
research with patients and healthcare organizations that can
provide these samples. The Marketplace specifically addresses
procurement inefficiencies that have traditionally forced
researchers to limit the scope of their work due to the shortage of
quality biospecimens. Researchers can search for biospecimens based
on demographic traits, medical conditions, procedures, blood type,
country of collection and much more.
About iSpecimeniSpecimen (Nasdaq: ISPC) offers
an online marketplace for human biospecimens, connecting scientists
in commercial and non-profit organizations with healthcare
providers that have access to patients and specimens needed for
medical discovery. Proprietary, cloud-based technology enables
scientists to intuitively search for specimens and patients across
a federated partner network of hospitals, labs, biobanks, blood
centers and other healthcare organizations. For more information,
please visit www.ispecimen.com.
Forward Looking StatementsThis press release
may contain forward-looking statements within the meaning of
Section 27A of the Securities Act of 1933, as amended, and Section
21E of the Securities Exchange Act of 1934, as amended. Such
forward-looking statements are characterized by future or
conditional verbs such as “may,” “will,” “expect,” “intend,”
“anticipate,” “believe,” “estimate” and “continue” or similar
words. You should read statements that contain these words
carefully because they discuss future expectations and plans, which
contain projections of future results of operations or financial
condition or state other forward-looking information.
Forward-looking statements are predictions, projections and
other statements about future events that are based on current
expectations and assumptions and, as a result, are subject to risks
and uncertainties. Many factors could cause actual future events to
differ materially from the forward-looking statements in this press
release, including but not limited to the risk factors contained in
the Company’s filings with the Securities and Exchange Commission,
which are available for review at www.sec.gov. Forward-looking
statements speak only as of the date they are made. New risks and
uncertainties arise over time, and it is not possible for the
Company to predict those events or how they may affect the Company.
If a change to the events and circumstances reflected in the
Company’s forward-looking statements occurs, the Company’s
business, financial condition and operating results may vary
materially from those expressed in the Company’s forward-looking
statements.
Readers are cautioned not to put undue reliance on
forward-looking statements, and the Company assumes no obligation
and do not intend to update or revise these forward-looking
statements, whether as a result of new information, future events
or otherwise.
For further information, please contact:
Investor ContactKCSA Strategic
CommunicationsAllison SossiSpecimen@kcsa.com
Media ContactsKCSA Strategic
CommunicationsRaquel Cona / Shana MarinoiSpecimen@kcsa.com
iSpecimen (NASDAQ:ISPC)
Historical Stock Chart
From Mar 2024 to Apr 2024
iSpecimen (NASDAQ:ISPC)
Historical Stock Chart
From Apr 2023 to Apr 2024